Wolfgang Holter

Author PubWeight™ 32.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008 3.12
2 Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. J Clin Oncol 2008 2.08
3 Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation. Blood 2011 1.16
4 Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection. PLoS One 2012 1.08
5 Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation. Blood 2006 1.06
6 [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents]. Strahlenther Onkol 2008 1.05
7 B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ. Blood 2013 1.02
8 Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated. J Invest Dermatol 2002 1.02
9 Dose finding study for the use of subcutaneous recombinant interleukin-2 to augment natural killer cell numbers in an outpatient setting for stage 4 neuroblastoma after megatherapy and autologous stem-cell reinfusion. J Clin Oncol 2010 0.97
10 Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia. Br J Haematol 2005 0.93
11 Efficient chemokine-dependent migration and primary and secondary IL-12 secretion by human dendritic cells stimulated through Toll-like receptors. J Immunother 2007 0.91
12 Ewing sarcoma of the mandible in a child: interdisciplinary treatment concepts and surgical reconstruction. J Craniofac Surg 2005 0.91
13 Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome. Med Pediatr Oncol 2003 0.89
14 Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses. Cancer Immunol Immunother 2005 0.89
15 Stem cell transplantation after reduced-intensity conditioning for sickle cell disease. Eur J Haematol 2013 0.87
16 SLAM-associated protein deficiency causes imbalanced early signal transduction and blocks downstream activation in T cells from X-linked lymphoproliferative disease patients. J Biol Chem 2003 0.87
17 First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantation. J Immunother 2014 0.86
18 Autocrine TNF is critical for the survival of human dendritic cells by regulating BAK, BCL-2, and FLIPL. J Immunol 2012 0.86
19 Defective T-helper cell function after T-cell-depleting therapy affecting naive and memory populations. Blood 2002 0.86
20 Plasticity of dendritic cell function in response to prostaglandin E2 (PGE2) and interferon-gamma (IFN-gamma). J Leukoc Biol 2008 0.85
21 Quantification of busulfan in saliva and plasma in haematopoietic stem cell transplantation in children : validation of liquid chromatography tandem mass spectrometry method. Clin Pharmacokinet 2006 0.83
22 T cells engineered with a cytomegalovirus-specific chimeric immunoreceptor. J Virol 2010 0.83
23 Hematopoietic stem cell transplantation and subsequent 80% skin exchange by grafts from the same donor in a patient with Herlitz disease. Transplantation 2005 0.82
24 Caspase-8 dependent apoptosis induction in malignant myeloid cells by TLR stimulation in the presence of IFN-alpha. Leuk Res 2007 0.82
25 Multiple relapses in high-grade osteosarcoma: when to stop aggressive therapy? Pediatr Blood Cancer 2014 0.81
26 Hematologic features and clinical course of an infant with Pearson syndrome caused by a novel deletion of mitochondrial DNA. J Pediatr Hematol Oncol 2003 0.79
27 Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription. Immunogenetics 2003 0.79
28 Childhood polyarteritis nodosa in autoimmune lymphoproliferative syndrome. Pediatrics 2009 0.77
29 Transformation efficiency by Herpesvirus saimiri is not a limiting factor in clonal CD8pos T cell outgrowth. Virology 2009 0.77
30 Novel MLL2 mutation in Kabuki syndrome with hypogammaglobulinemia and severe chronic thrombopenia. J Pediatr Hematol Oncol 2013 0.76
31 Simultaneous control of third-degree graft-versus-host disease and prevention of recurrence of juvenile myelomonocytic leukemia (JMML) with 6-mercaptopurine following fulminant JMML relapse early after KIR-mismatched bone marrow transplantation. J Pediatr Hematol Oncol 2005 0.76
32 Functional characterization of monocyte-derived dendritic cells generated under serumfree culture conditions. Immunol Lett 2005 0.76
33 Malignant epithelioid peripheral nerve sheath tumor with prominent reticular/microcystic pattern in a child: a low-grade neoplasm with 18-years follow-up. Appl Immunohistochem Mol Morphol 2014 0.76
34 Pediatric Acute Lymphoblastic Leukemia: Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia. Haematologica 2013 0.76
35 Temporary blast reduction after immunoglobulin administration for congenital cytomegalovirus infection masking infant leukemia with cryptic MLL rearrangement. Leuk Res 2006 0.75
36 MHC class II antigen signaling induces homotypic and heterotypic cluster formation of human mature monocyte derived dendritic cells in the absence of cell death. Hum Immunol 2003 0.75
37 Aplastic anemia following hepatitis associated with human herpesvirus 6. J Pediatr Gastroenterol Nutr 2010 0.75
38 An unusual thyroid mass in a 5-year-old girl. J Pediatr 2012 0.75
39 Recurrent gross hematuria with positive family history of IgA nephropathy and an unexpected diagnosis. Urology 2011 0.75
40 Successful stem cell mobilization with stem cell factor and granulocyte colony-stimulating factor in patients with solid tumors failing conventional mobilization with chemotherapy and G-CSF. J Hematother Stem Cell Res 2003 0.75